NCT03895905View on ClinicalTrials.gov

Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity

CompletedOBSERVATIONAL

Enrollment

409

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 1, 2018

Study Completion Date

January 1, 2019

Conditions

Human Papilloma VirusCervical Neoplasm

Interventions

DIAGNOSTIC_TEST

colposcopy and colposcopic biopsy

high-risk hpv positivity and colposcopy and cervical biopsy results will be evaluated. thus, it will be defined whether colposcopy will be performed routinely at high-risk hpv.

Trial Locations (1)

33404

Kanuni Sultan Süleyman Training and Research Hospital, Istanbul

All Listed Sponsors

lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT03895905 - Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity | Biotech Hunter | Biotech Hunter